The Cochrane Infectious Diseases Group (CIDG) editorial base in Liverpool thanks its readers, authors, referees, and editors for their support and contributions to the CIDG's work throughout 2021. In this end of year newsletter, we reflect on the challenges and achievements of 2021 and plans for 2022.
What's new! CIDG publications November 2021
Are rotavirus vaccines safe and effective in preventing rotavirus diarrhoea in infants and children?
What is it like as a young woman facing a health worker who tells you that you are infected with HIV and need to take drugs for the rest of your life?
What's new! CIDG publications September 2021
What's new! CIDG Publications July/August 2021
To assess the efficacy and safety of ivermectin compared to no treatment, standard of care, placebo, or any other proven intervention for people with COVID‐19 receiving treatment as inpatients or outpatients, and for prevention of an infection with SARS‐CoV‐2 (postexposure prophylaxis).
What's new! CIDG Publications June 2021
New CIDG review assesses the effect of community administration of ivermectin on malaria transmission
During May, READ-It Partners published the following reviews, and articles.
What's new! CIDG Publications May 2021